References
1. American Psychiatric Association. Diagnostic and Statistic manual. 2003.
2. Heller MM, Wong JW, Lee ES, Ladizinski B, Grau M, Howard JL, et al. Delusional infestations: Clinical presentation, diagnosis and treatment. Int J Dermatol. 2013;52(7):775–83.
3. Waykar V, Wourms K, Tang M, Joseph V. Delusional infestation : an interface with psychiatry. 2020;1–6.
4. Moriarty N, Alam M, Kalus A, O’Connor K. Current Understanding and Approach to Delusional Infestation. Am J Med [Internet]. 2019;132(12):1401–9. Available from: https://doi.org/10.1016/j.amjmed.2019.06.017
5. Al-Imam A, Al-Shalchi A. Ekbom’s Delusional Parasitosis: A Systematic Review. Egypt J Dermatology Venerol. 2019;39(1):5.
6. Torales J, García O, Barrios I, O’Higgins M, Castaldelli-Maia JM, Ventriglio A, et al. Delusional infestation: Clinical presentations, diagnosis, and management. J Cosmet Dermatol. 2020;19(12):3183–8.
7. Assalman I, Ahmed A, Alhajjar R, Ap B, Taylor R, Assalman I, et al. Treatments for primary delusional infestation ( Review ). 2019;
8. Dridi A, Maamri A, Ben Mustapha MA, Hamzaoui S, Zalila H. Ekbom’s Syndrome: a Case Report. Eur Psychiatry [Internet]. 2015;30:1453. Available from: http://dx.doi.org/10.1016/S0924-9338(15)31126-3
9. Blank MB, Mandell DS, Aiken L, Hadley TR. Co-occurrence of HIV and serious mental illness among medicaid recipients. Psychiatr Serv. 2002;53(7):868–73.
10. Middelveen MJ, Fesler MC, Stricker RB. History of Morgellons disease: From delusion to definition. Clin Cosmet Investig Dermatol. 2018;11:71–90.
11. Schouten J, Cinque P, Gisslen M, Reiss P, Portegies P. HIV-1 infection and cognitive impairment in the cART era: A review. Aids. 2011;25(5):561–75.
12. Rosca EC, Tadger P, Cornea A, Tudor R, Oancea C, Simu M. International hiv dementia scale for hiv-associated neurocognitive disorders: A systematic review and meta-analysis. Diagnostics. 2021;11(6).
13. Alford K, Banerjee S, Nixon E, O’brien C, Pounds O, Butler A, et al. Assessment and management of HIV-associated cognitive impairment: Experience from a multidisciplinary memory service for people living with HIV. Brain Sci. 2019;9(2):1–13.
14. Bhaskaran K, Mussini C, Antinori A, Walker AS, Dorrucci M, Sabin C, et al. Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy. Ann Neurol. 2008;63(2):213–21.
15. Ciccarelli N, Fabbiani M, Di Giambenedetto S, Fanti I, Baldonero E, Bracciale L, et al. Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients. Neurology. 2011;76(16):1403–9.
16. Sampogna F, Abeni D, Gieler U, Tomas-Aragones L, Lien L, Titeca G, et al. Impairment of sexual life in 3,485 dermatological outpatients from a multicentre study in 13 European countries. Acta Derm Venereol. 2017;97(4):478–82.
17. Guerrero-Jiménez M, Carrillo De Albornoz Calahorro CM, Girela-Serrano B, Bodoano Sánchez I, Gutiérrez-Rojas L. Post-Psychotic Depression: An Updated Review of the Term and Clinical Implications. Psychopathology. 2022;55(2):82–92.
18. Birchwood M, Iqbal Z, Upthegrove R. Psychological pathways to depression in schizophrenia: Studies in acute psychosis, post psychotic depression and auditory hallucinations. Eur Arch Psychiatry Clin Neurosci. 2005;255(3):202–12.
19. Sönmez N, Romm KL, Andreasssen OA, Melle I, Røssberg JI. Depressive symptoms in first episode psychosis: A one-year follow-up study. BMC Psychiatry. 2013;13.
20. Danivas V, Lepping P, Punitharani S, Gowrishree H, Ashwini K, Raveesh BN, et al. Observational study of aggressive behaviour and coercion on an Indian acute ward. Asian J Psychiatr [Internet]. 2016;22:150–6. Available from: http://dx.doi.org/10.1016/j.ajp.2016.06.004